OVERVIEW

This course is a collaboration between Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow and researchers in the Division of General Internal Medicine at the University of Pennsylvania

Who is the course aimed at?

The course is designed for individuals undertaking health economic evaluations in academia, consultancies and industry, as well as those involved in the design and analysis of clinical trials (statisticians and health service researchers).

What are the learning objectives of the course?

By the end of the course, participants will be able to:

• Design an economic evaluation in a clinical trial appropriate to a setting or intervention(s), including multinational RCTs
• Analyse cost and effect data using univariate and multivariate approaches
• Estimate cost effectiveness (and net benefit) and the uncertainty surrounding the estimate
• Consider issues of transferability

What will the course cover?

The course will start with designing a multinational trial and consider the issues of evaluating data from such a trial (what data to collect, how to value cost and effect, how to analyse the data, and estimate cost effectiveness) as building blocks over the three days.

Specific exercises will be conducted to illustrate the effect of distributional assumptions, univariate and multivariable approaches for the analysis of costs and QALYs, sample size and power calculations and their interpretation, reporting sampling uncertainty for the comparison of cost and effects.

Software and prerequisites

This is course focuses specifically on the analysis of cost and effect data in an economic evaluation alongside a clinical trial. Participants are expected to be familiar with t-tests and ordinary least squares regression.  Familiarity with sample size calculation for clinical outcomes will be helpful but not required.

The course will be 'hands-on', and participants are required to bring a laptop computer (and mouse).  The course will use STATA and enrolled participants who do not have STATA will be provided with a temporary STATA licence.  Familiarity with STATA is not necessary, but will be beneficial.

The statistical modules will involve computer work on exercises which will be built up over the three days. In addition, participants will be given the opportunity to bring along their own evaluations for further development during the course.

The next run of the course will take place on 30th October - 1st November 2013 at the Hilton Glasgow Grosvenor, Glasgow.  This year we have added an optional one-day Introduction to Stata course, which will run on Tuesday 29th October.  Please note there is no additional charge for this for anyone attending the Economic Evaluation in Clinical Trials course.

Please contact Caroline Cecil, Research Administrator, HEHTA, Institute of Health & Wellbeing, University of Glasgow on 0141 330 5292 or e-mail ihw-hehta@glasgow.ac.uk for more information.

The Glasgow course will take place at the Hilton Glasgow Grovesnor Hotel, situated in the lively West End of the City near the University with many shops, bars and restuarants. It is also only a short underground trip away from the City Centre. The course is non-residential. Limited accommodation will be available at a reduced rate at the Hilton Glasgow Grovesnor, please contact our Conference and Visitor Services Office for details (see below).  There are also many hotels and bed & breakfast accommodation within walking distance.

A map showing the locations of some hotels in the West End and the City Centre is available from Caroline Cecil, HEHTA Administrator at ihw-hehta@glasgow.ac.uk. More details about accommodation and a hotel booking service are available from the University of Glasgow's Conference & Visitor Services Office.

Travel directions, a University map and information about Glasgow University is available from: http://www.gla.ac.uk/about/maps/

• Andrew Briggs, DPhil, Health Economics and Health Technology Assessment, University of Glasgow. Andrew Briggs was appointed to the Lindsay Chair in Health Policy and Economic Evaluation in June 2005. Andrew has an interest in all aspects of economic evaluation applied to health care, in particular the use of statistical methods for assessing cost and cost-effectiveness, and the use of risk/prognostic modelling for making treatment decisions and guiding policy. 
• Henry Glick, PhD, Division of General Internal Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania. Henry has more than 20 years of experience in conducting economic assessments of medical therapies. He specializes in economic assessments conducted as part of clinical trials. In addition, he has extensive experience with decision analysis, preference assessment, analysis of observational data, and the evaluation of diagnostic tests.
• Jalpa Doshi, PhD, Division of General Internal Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania. Jalpa's research interests revolve around economic and outcomes assessments of medication use and adherence using observational as well as randomised trial data. She has extensive experience conducting evaluations using Medicare, Medicaid, VA and commercial insurance datasets. 
• Elisabeth Fenwick, PhD, Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow. Elisabeth is a Senior Lecturer in Health Economics and her research interests include decision modelling in economic evaluation, handling uncertainty and the use of Bayesian methods for health technology in assessment.
• Jim Lewsey, Health Economics and Health Technology Assessment, University of Glasgow. Jim is a Senior Lecturer in Medical Statistics and his research interests stem from methodological challenges faced when analysing observational and experimental medical data.  His current interests include competing risks and multi-state survival analysis.

In addition, tutors from Glasgow will be involved in all practical exercises to ensure that there will be approximately one Faculty member for every five participants.

The next run of the course will be on 30th October - 1st November 2013 at the Hilton Grosvenor Glasgow, Glasgow.

Please contact Caroline Cecil, Research Administrator, HEHTA, Institute of Health & Wellbeing, University of Glasgow on 0141 330 5292 or e-mail ihw-hehta@glasgow.ac.uk for more information.

2013 fees

Public/academic £950
Commercial sector £1,480

Fees are fully inclusive of tuition, lunch, course dinner, and course materials but do not include accommodation. VAT is not payable.

Cancellation

The fee is payable in advance. A refund of the course fee (less 10% administrative charge) will be made for cancellations received in writing up to one month prior to the course date (30th September 2013).  Cancellations made after that date are non refundable. Substitutions are allowed but please fax new delegate details when known.